Immunohistochemical analysis showed that LAT1 expression correlates with lymphoma grade, so inhibition of LAT1 is expected to be effective for aggressive types of NHL with higher cell proliferation rate. This evidence concerns the gene LAT and non-Hodgkin lymphoma.